Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Johnson

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|October 25, 2002
Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern ChineseAndrew Siu Chung Chan, Ka Fai To, Kwok Wai Lo, et al.
Human Mutation|July 28, 2007
The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutationsPaolo Comeglio, Philip Johnson, Gavin Arno, et al.
Anesthesia and Analgesia|August 8, 2013
Peripheral nerve injury after local anesthetic injectionScott J Farber, Maryam Saheb-Al-Zamani, Lawrence Zieske, et al.
European Journal of Gastroenterology & Hepatology|May 1, 2013
Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspectiveMassimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 6, 2018
The Utility of a Benign Biliary Stricture Protocol in Preventing Symptomatic Recurrence and Surgical RevisionDaniel L Kirkpatrick, Hasnain Hasham, Zachary Collins, et al.
Journal of Pain and Symptom Management|December 31, 2002
Quality of life of palliative care patients in the last two weeks of lifeRaymond S K Lo, Jean Woo, Karen C H Zhoc, et al.
JAMA|November 18, 2010
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trialGhassan K Abou-Alfa, Philip Johnson, Jennifer J Knox, et al.
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancerTony S K Mok, Thomas W T Leung, Gill Brown, et al.
Cancer Treatment Reviews|July 12, 2021
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysisJulien Edeline, Angela Lamarca, Mairéad G McNamara, et al.
Journal of Gastroenterology and Hepatology|May 14, 2015
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinomaStephen L Chan, Frankie Mo, Philip Johnson, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|October 25, 2002
Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern ChineseAndrew Siu Chung Chan, Ka Fai To, Kwok Wai Lo, et al.
Human Mutation|July 28, 2007
The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutationsPaolo Comeglio, Philip Johnson, Gavin Arno, et al.
Anesthesia and Analgesia|August 8, 2013
Peripheral nerve injury after local anesthetic injectionScott J Farber, Maryam Saheb-Al-Zamani, Lawrence Zieske, et al.
European Journal of Gastroenterology & Hepatology|May 1, 2013
Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspectiveMassimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 6, 2018
The Utility of a Benign Biliary Stricture Protocol in Preventing Symptomatic Recurrence and Surgical RevisionDaniel L Kirkpatrick, Hasnain Hasham, Zachary Collins, et al.
Journal of Pain and Symptom Management|December 31, 2002
Quality of life of palliative care patients in the last two weeks of lifeRaymond S K Lo, Jean Woo, Karen C H Zhoc, et al.
JAMA|November 18, 2010
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trialGhassan K Abou-Alfa, Philip Johnson, Jennifer J Knox, et al.
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancerTony S K Mok, Thomas W T Leung, Gill Brown, et al.
Cancer Treatment Reviews|July 12, 2021
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysisJulien Edeline, Angela Lamarca, Mairéad G McNamara, et al.
Journal of Gastroenterology and Hepatology|May 14, 2015
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinomaStephen L Chan, Frankie Mo, Philip Johnson, et al.
Pageof 10